Featured news from NHIVNA

HIV-related news from NAM

Spanish vaccine induces viral control off ART in nearly 40% of recipients
Gus Cairns, 2017-02-17 14:00:00

A so-called ‘HIV Conserv’ vaccine has, for the first time, produced significant prolonged viral control in a large minority of recipients once they were taken off antiretroviral therapy (ART). So far, one participant has stayed off ART for seven months without having to resume it. Presenting at the Conference on Retroviruses and Opportunistic Infections (CROI 2017), Beatriz Mothe said that viral control in recipients of the vaccine occurred more frequently than spontaneous control of HIV seen in previous studies of treatment interruption.

Although a number of vaccine studies in monkeys have produced long-term viral suppression, this is the first human study to produce such an effect.